AstraZeneca Says SERENA-4 Phase III Trial Of Etcamah With Palbociclib Does Not Meet Primary Endpoint
AstraZeneca PLC LSE:AZN
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.